NCT06041490 2023-09-18
Adjuvant Therapy for High-risk Hepatocellular Carcinoma Post Liver Transplantation
Peking Union Medical College Hospital
Phase 2 Not yet recruiting
Peking Union Medical College Hospital
St. Jude Children's Research Hospital
Innovent Biologics (Suzhou) Co. Ltd.